Literature DB >> 23839200

IncobotulinumtoxinA in esthetics.

Martina Kerscher1, Yana Yutskovskaya, Timothy Corcoran Flynn.   

Abstract

IncobotulinumtoxinA (Xeomin®/Xeomeen®/Bocouture®/XEOMIN Cosmetic™) is a botulinum toxin type A that differs from other commercially available botulinum toxin type A preparations in that it is free from complexing proteins ([150 kDa]/NT 201). The proven efficacy of incobotulinumtoxinA in various therapeutic indications preceded its use in the field of esthetic medicine, where it is widely approved for the treatment of glabellar frown lines on the basis of positive efficacy and safety findings from a number of clinical trials. Here, we discuss the characteristics of incobotulinumtoxinA and review the clinical data supporting its use in esthetics.

Mesh:

Substances:

Year:  2013        PMID: 23839200

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.

Authors:  Gabriele F Muti; Matteo Basso
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

2.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.